HbA1c

Diabeloop presents new real-life results of DBLG1® System: Confirmed improvement in Time In Range +18.4 percentage points; Reduction of time spent in hypoglycemia to only 0.9%

(PRESS RELEASE) PARIS, 28-Apr-2022 — /EuropaWire/ — ATTD 2022 - Diabeloop, pioneer in therapeutic artificial intelligence for diabetes management, presents…

2 years ago

Significant improvement in increasing Time In Range and reducing hypoglycemia among people equipped with Diabeloop DBLG1

EASD 2021 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data(1) of its…

3 years ago